195 related articles for article (PubMed ID: 15899809)
1. Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Avis I; Martínez A; Tauler J; Zudaire E; Mayburd A; Abu-Ghazaleh R; Ondrey F; Mulshine JL
Cancer Res; 2005 May; 65(10):4181-90. PubMed ID: 15899809
[TBL] [Abstract][Full Text] [Related]
2. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
3. Selective activation of PPARgamma in breast, colon, and lung cancer cell lines.
Allred CD; Kilgore MW
Mol Cell Endocrinol; 2005 May; 235(1-2):21-9. PubMed ID: 15866424
[TBL] [Abstract][Full Text] [Related]
4. Human multiple myeloma cells express peroxisome proliferator-activated receptor gamma and undergo apoptosis upon exposure to PPARgamma ligands.
Ray DM; Bernstein SH; Phipps RP
Clin Immunol; 2004 Nov; 113(2):203-13. PubMed ID: 15451478
[TBL] [Abstract][Full Text] [Related]
5. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
Zhang M; Zou P; Bai M; Tao XN; Jin Y; Guo R
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1169-72. PubMed ID: 12921638
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
Cheng J; Nakamura H; Imanishi H; Liu W; Morisaki T; Sugiyama T; Hada T
Biochem Biophys Res Commun; 2004 Sep; 322(2):458-64. PubMed ID: 15325252
[TBL] [Abstract][Full Text] [Related]
8. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells.
James SY; Lin F; Kolluri SK; Dawson MI; Zhang XK
Cancer Res; 2003 Jul; 63(13):3531-8. PubMed ID: 12839938
[TBL] [Abstract][Full Text] [Related]
9. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma.
Yuan J; Takahashi A; Masumori N; Uchida K; Hisasue S; Kitamura H; Itoh N; Tsukamoto T
Urology; 2005 Mar; 65(3):594-9. PubMed ID: 15780399
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
Kaplan J; Cook JA; O'Connor M; Zingarelli B
Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of oxidant production by peroxisome proliferator-activated receptor ligands from cell death in human cell lines.
Atarod EB; Kehrer JP
Free Radic Biol Med; 2004 Jul; 37(1):36-47. PubMed ID: 15183193
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells.
Vondrácek J; Stika J; Soucek K; Minksová K; Bláha L; Hofmanová J; Kozubík A
Eur J Pharmacol; 2001 Jul; 424(1):1-11. PubMed ID: 11470254
[TBL] [Abstract][Full Text] [Related]
13. 15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.
Chen ZY; Tseng CC
Mol Pharmacol; 2005 Nov; 68(5):1203-13. PubMed ID: 16077033
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
Walther U; Emmrich K; Ramer R; Mittag N; Hinz B
Oncotarget; 2016 Mar; 7(9):10345-62. PubMed ID: 26863638
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886.
Kehrer JP; Biswal SS; La E; Thuillier P; Datta K; Fischer SM; Vanden Heuvel JP
Biochem J; 2001 Jun; 356(Pt 3):899-906. PubMed ID: 11389700
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Takahashi Y; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Int J Oncol; 2003 Aug; 23(2):325-31. PubMed ID: 12851681
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells.
Galli A; Crabb D; Price D; Ceni E; Salzano R; Surrenti C; Casini A
Hepatology; 2000 Jan; 31(1):101-8. PubMed ID: 10613734
[TBL] [Abstract][Full Text] [Related]
18. Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability.
Smith SA; Monteith GR; Holman NA; Robinson JA; May FJ; Roberts-Thomson SJ
J Neurosci Res; 2003 Jun; 72(6):747-55. PubMed ID: 12774315
[TBL] [Abstract][Full Text] [Related]
19. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
Yamazaki K; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Kanemura N; Araki H; Tsurumi H; Kojima S; Weinstein IB; Moriwaki H
Gut; 2007 Nov; 56(11):1557-63. PubMed ID: 17604322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
